Development and validation of a bioanalytical LC-MS method for the quantification of GHRP-6 in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 60, Issue , 2012, Pages 19-25

  Gil, Jeovanis ^a   Cabrales, Ania ^a   Reyes, Osvaldo ^a   Morera, Vivian ^a   Betancourt, Lázaro ^a   Sánchez, Aniel ^a   García, Gerardo ^a   Moya, Galina ^a   Padrón, Gabriel ^a   Besada, Vladimir ^a   González, Luis Javier ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

GHRP 6; Internal standard; LC MS; Method validation; Plasma

Indexed keywords

ACETONE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; PLASMA PROTEIN;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE 1 CLINICAL TRIAL (TOPIC); PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; STANDARD; VALIDATION PROCESS; VALIDATION STUDY;

ALANINE; CARBON ISOTOPES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIMIT OF DETECTION; OLIGOPEPTIDES; PLANT PROTEINS; REFERENCE STANDARDS; TRANSCRIPTION FACTORS;

EID: 83955163610     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.11.007     Document Type: Article

References (30)

1. Deghenghi R., Cananzi M.M., Torsello A., Battisti C., Muller E.E., Locatelli V. GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 1994, 54:1321-1328.
2. Smith R.G., Palyha O.C., Feighner S.D., Tan C.P., McKee K.K., Hreniuk D.L., Yang L., Morriello G., Nargund R., Patchett A.A., Howard A.D. Growth hormone releasing substances: types and their receptors. Horm. Res. 1999, 51(Suppl. 3):1-8.
3. Sugino T., Hasegawa Y., Kurose Y., Kojima M., Kangawa K., Terashima Y. Effects of ghrelin on food intake and neuroendocrine function in sheep. Anim. Reprod. Sci. 2004, 82-83:183-194.
4. Schuessler P., Uhr M., Ising M., Schmid D., Weikel J., Steiger A. Nocturnal ghrelin levels - relationship to sleep EEG, the levels of growth hormone, ACTH and cortisol - and gender differences. J. Sleep Res. 2005, 14:329-336.
5. Cibrián D., Ajamieh H., Berlanga J., León O.S., Alba J.S., Kim M.J., Marchbank T., Boyle J.J., Freyre F., Garcia Del Barco D., Lopez-Saura P., Guillen G., Ghosh S., Goodlad R.A., Playford R.J. Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clin. Sci. (Lond.) 2006, 110:563-573.
6. Berlanga J., Cibrian D., Guevara L., Dominguez H., Alba J., Seralena A., Guillen G., Lopez-Mola E., Lopez-Saura P., Rodriguez A., Perez B., Garcia D., Vispo N.S. Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction. Clin. Sci. (Lond.) 2007, 112:241-250.
7. Casanueva F., Dieguez C. Growth hormone secretagogues: physiological role and clinical utility. Trends Endocrinol. Metab. 1999, 10:30-38.
8. Gelpi E. Biomedical and biochemical applications of liquid chromatography-mass spectrometry. J. Chromatogr. A 1995, 703:59-80.
9. Peng J., Gygi S. Proteomics: the move to mixtures. J. Mass Spectrom. 2001, 36:1083.
10. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
11. Washburn M., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19:242-247.
12. Stemmann O., Zou H., Gerber S., Gygi S., Kirschner M. Dual inhibition of sister chromatid separation at metaphase. Cell 2001, 107:715-726.
13. Darby S., Miller M., Allen R., LeBeau M. A mass spectrometric method for quantitation of intact insulin in blood samples. J. Anal. Toxicol. 2001, 25:8-14.
14. Chang D., Kolis S.J., Linderholm K.H., Julian T.F., Nachi R., Dzerk A.M., Lin P.P., Lee J.W., Bansal S.K. Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS/MS. J. Pharm. Biomed. Anal. 2005, 38:87-496.
15. Okano M., Sato M., Ikekita A., Kageyama S. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24:2046-2056.
16. Thomas A., Kohler M., Mester J., Geyer H., Schänzer W., Petrou M., Thevis M. Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Drug Test Anal. 2010, 2:144-148.
17. Thomas A., Höppner S., Geyer H., Schänzer W., Petrou M., Kwiatkowska D., Pokrywka A., Thevis M. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry. Anal. Bioanal. Chem. 2011, 401:507-516.
18. Fouda H., Nocerini M., Schneider R., Gedutis C. Quantitative analysis by high-performance liquid chromatography atmospheric pressure chemical ionization mass spectrometry: the determination of the renin inhibitor CP-80, 794 in human serum. J. Am. Soc. Mass Spectrom. 1991, 2:64-167.
19. Wang-Iverson D., Arnold M.E., Jemal M., Cohen A.I. Determination of SQ 33,600, a phosphinic acid containing HMG CoA reductase inhibitor, in human serum by high-performance liquid chromatography combined with ionspray mass spectrometry. Biol. Mass Spectrom. 1992, 21:189-194.
20. Covey T.R., Lee E.D., Henion J.D. High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples. Anal. Chem. 1986, 58:2453-2460.
21. Kaye B., Clark M.W.H., Cussans N.J., Macrae P.V., Stopher D.A. The sensitive determination of abanoquil in blood by high-performance liquid chromatography/atmospheric pressure ionization mass spectrometry. Biol. Mass Spectrom. 1992, 21:585-589.
22. Wan H., Desiderio D.M. Quantification of [Dmt1] DALDA in ovine plasma by on-line liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2003, 17:538-546.
23. Dadgar D., Burnett P.E., Choc M.G., Gallicano K., Hooper J.W. Application issues in bioanalytical method validation, sample analysis and data reporting. J. Pharm. Biomed. Anal. 1995, 13:89-97.
24. Fields G.B., Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990, 35:161-214.
25. McEntire J. Selection and validation of analytical techniques. BioPharm 1994, 7:68-80.
26. John H., Walden M., Schafer S., Genz S., Forssmann W.G. Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry. Anal. Bioanal. Chem. 2004, 378:883-897.
27. Bateman R.H., Carruthersa R., Hoyesa J.B., Jonesa C., Langridgea J.I., Millara A., Vissersa J.P.C. A novel precursor ion discovery method on a hybrid quadrupole orthogonal acceleration time-of-flight (Q-TOF) mass spectrometer for studying protein phosphorylation. J. Am. Soc. Mass Spectrom. 2002, 13:92-803.
28. FDA Guidance for Industry, Bioanalytical Method Validation May 2001.
29. Bansal S., DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J. 2007, 9:E109-E114.
30. Powell M.F., Stewart T., Otvos L., Urge L., Gaeta F.C.A., Sette A., Arrhenius T., Thomson D., Soda K., Colon S.M. Peptide stability in drug development II: effect of single amino acid substitution and glycosylation on peptide reactivity in human serum. Pharm. Res. 1993, 10:1268-1273.